Global Immunoassay Market Is Set Anticipated To Reach Around USD 29.79 Billion By 2025

21-Feb-2019 | Zion Market Research

Zion Market Research has published a new report titled “Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, and Software & Services), by Platform (Chemiluminescence Immunoassays, Fluorescence Immunoassays, Enzyme Immunoassays, Radioimmunoassay, and Others), by Technology (ELISA, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Others), by Application (Infectious Disease, Endocrinology, Oncology, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, and Others), and by End-User (Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global immunoassay market was valued approximately USD 19.17 billion in 2018 and is expected to generate around USD 29.79 billion by 2025, at a CAGR of around 6.5% between 2019 and 2025.

Immunoassay is a type of biochemistry technique that is used either qualitatively or quantitatively to detect the presence of analytes. The analytes present can be in the form of large proteins or antibodies that may be produced due to an infection. This type of test can be used in laboratories or at the site itself. Antibodies or antigens are used as biorecognition agents for detecting the presence of analytes. The growing prevalence of other chronic and infectious diseases, such as tuberculosis, AIDS, etc., is projected to further fuel the immunoassay market over the estimated timeframe.

Browse the full “Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, and Software & Services), by Platform (Chemiluminescence Immunoassays, Fluorescence Immunoassays, Enzyme Immunoassays, Radioimmunoassay, and Others), by Technology (ELISA, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Others), by Application (Infectious Disease, Endocrinology, Oncology, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, and Others), and by End-User (Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/immunoassay-market

Global Immunoassay Market

The global immunoassay market is divided into product and service, technology, application, platform, and end-user. By product and service, the market is divided into reagents and kits, software and services, and analyzers. The reagents and kits segment is anticipated to dominate the immunoassay market over the forecast time period, owing to the increasing prevalence of chronic and infectious diseases

By platform, the immunoassay market is segmented into fluorescence immunoassays, radioimmunoassays, enzyme immunoassays, chemiluminescence immunoassays, and others. The enzyme immunoassays segment is anticipated to grow considerably in the global market due to its accurate results related to the detection of various diseases.

By technology, the market is segmented into ELISA, ELISPOT, immuno-PCR, rapid tests, western blotting, and others. ELISA dominated the market in 2018, due to its use in the detection of various diseases, such as cancer, infectious disease, and detection and monitoring of the therapeutic drug level.

The application segment of the market includes oncology, endocrinology, cardiology, infectious diseases, autoimmune disorders, hematology and blood screening, and others. Infectious diseases are expected to dominate the immunoassay market in the upcoming years, owing to the growing prevalence of tuberculosis in developing nations, such as India and China. The oncology segment is expected to show the highest growth rate in the future, owing to the increasing number of people suffering from cancer and growing research and development activities related to cancer.

By end-user, the market is segmented into pharmaceutical and biotechnology companies, clinical laboratories, contract research organization, hospitals, and others. Hospitals are anticipated to dominate the immunoassay market globally, owing to the presence of laboratories conducting diagnosis and tests and their high patient pool suffering from chronic diseases.

By region, North America is projected to dominate the global immunoassay market in the upcoming years, owing to rising healthcare expenditure, increasing prevalence of chronic diseases, and growing research activities related to immunological disorders. The Asia Pacific immunoassay market is projected to show the highest rate of growth over the forecast time period, owing to the rising prevalence of infectious diseases in China and India, increasing product launches, growing investments made in R&D by the government, and increased establishments of the pharmaceutical and biotechnological companies.

Some key players of the global immunoassay market are Siemens, Roche, Abbott Laboratories, Danaher Corporation, QIAGEN, Thermo Fischer Scientific, Bio-Rad Laboratories, Agilent Technologies, bioMerieux, Merck, Bio-Techne Corporation, and PerkinElmer.

This report segments the global immunoassay market into:

Global Immunoassay Market: Product and Service Analysis

  • Reagents and Kits
  • Analyzers
  • Software and Services
  • Global Immunoassay Market: Platform Analysis
  • Chemiluminescence Immunoassays (CLIAs)
  • Fluorescence Immunoassays (FIAs)
  • Enzyme Immunoassays (EIs)
  • Radioimmunoassays (RIAs)
  • Others

Global Immunoassay Market: Technology Analysis

  • ELISA
  • Rapid Tests
  • Western Blotting
  • ELISPOT
  • Immuno-PCR
  • Others

Global Immunoassay Market: Application Analysis

  • Infectious Disease
  • Endocrinology
  • Oncology
  • Cardiology
  • Hematology and Blood Screening
  • Autoimmune Disorders
  • Others

Global Immunoassay Market: End-User Analysis

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical and Biotechnology Companies 
  • Contract Research Organizations (CROs)
  • Blood Banks
  • Others

Global Immunoassay Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social